Cargando…

Once-daily tigecycline for outpatient parenteral antibiotic therapy: a single-centre observational study

BACKGROUND: Tigecycline has potential utility in the treatment of complex polymicrobial infections or those caused by MDR organisms in the ambulatory care setting owing to its breadth of antimicrobial coverage. Whilst licensed for twice-daily IV administration, its long half-life permits once-daily...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hughes, Stephen, Chin, Hui Yin, Heard, Katie L, Kamranpour, Pegah, Bartholomew, Brent, Mughal, Nabeela, Moore, Luke S P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210309/ https://www.ncbi.nlm.nih.gov/pubmed/34222958 http://dx.doi.org/10.1093/jacamr/dlz085

Ejemplares similares

Optimization of antimicrobial dosing in patients with acute kidney injury: a single-centre observational study
por: Hughes, Stephen, et al.
Publicado: (2022)

Clinical outcomes of temocillin use for invasive Enterobacterales infections: a single-centre retrospective analysis
por: Heard, Katie L, et al.
Publicado: (2021)

Evaluation of a thrice weekly administration of teicoplanin in the outpatient setting: a retrospective observational multicentre study
por: Asumang, John, et al.
Publicado: (2021)

COVID-19 and fungal superinfection
por: Heard, Katie L, et al.
Publicado: (2020)

Once Daily High Dose Tigecycline Is Optimal: Tigecycline PK/PD Parameters Predict Clinical Effectiveness
por: Baron, Jeffrey, et al.
Publicado: (2018)

Evaluating the impact of the ICNET® clinical decision support system for antimicrobial stewardship
por: Heard, Katie L., et al.
Publicado: (2019)

Update on once-daily zonisamide monotherapy in partial seizures
por: Afra, Pegah, et al.
Publicado: (2014)

Haematological and hepatic adverse effects of ceftriaxone in ambulatory care: a dual-centre retrospective observational analysis of standard vs high dose
por: Mistry, Rakhee, et al.
Publicado: (2022)

Procalcitonin to Guide Antibacterial Prescribing in Patients Hospitalised with COVID-19
por: Hughes, Stephen, et al.
Publicado: (2021)

Multidrug resistant Acinetobacter nosocomial meningitis treated successfully with parenteral tigecycline
por: Wadi, Jamal Ahmad, et al.
Publicado: (2007)

A single centre experience of prosthetic joint infection outcomes with outpatient parenteral antimicrobial therapy
por: Kutubi, Abdubadie, et al.
Publicado: (2023)

Bacteraemia variation during the COVID-19 pandemic; a multi-centre UK secondary care ecological analysis
por: Denny, Sarah, et al.
Publicado: (2021)

Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis
por: Tu, Jacky, et al.
Publicado: (2023)

Once-daily dosing of gentamicin.
por: Soper, D E
Publicado: (1998)

OPAT: outpatient parenteral antimicrobial therapy
Publicado: (2020)

Outpatient parenteral antimicrobial therapy in Brazil
por: Oliveira, Priscila R, et al.
Publicado: (2023)

Managing an outpatient parenteral antibiotic therapy team: challenges and solutions
por: Halilovic, Jenana, et al.
Publicado: (2014)

First Pediatric Outpatient Parenteral Antibiotic Therapy Clinic in Indonesia
por: Hendarto, Aryono, et al.
Publicado: (2020)

ONCE DAILY RISPERIDONE IN TREATMENT OF SCHIZOPHRENIA
por: Agarwal, Vivek, et al.
Publicado: (2001)

1935. Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
por: Blaskewicz, Caitlin, et al.
Publicado: (2018)

Safety of Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
por: Shrestha, Nabin K, et al.
Publicado: (2020)

Recommendations for outpatient parenteral antimicrobial therapy in Brazil
por: Oliveira, Priscila R., et al.
Publicado: (2017)

A broader view on outpatient parenteral antibiotic therapy (OPAT) stewardship
por: Hess, Danielle, et al.
Publicado: (2022)

Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
por: Toyos, Melissa M.
Publicado: (2019)

Outpatient parenteral antimicrobial therapy for leishmaniasis: 13 years’ experience at a large UK infectious diseases centre
por: Parkash, Vivak, et al.
Publicado: (2023)

608. Impact of Implementing Pharmacist Review and Monitoring of Outpatient Parenteral Antimicrobial Therapy
por: Kirkpatrick, Emily R, et al.
Publicado: (2020)

Benefits of once-daily therapies in the treatment of hypertension
por: Flack, John M, et al.
Publicado: (2011)

ONCE DAILY LITHIUM IN THE PROPHYLAXIS OF MOOD DISORDERS
por: Mohan, Rajesh, et al.
Publicado: (1996)

Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin
por: Kapitza, C, et al.
Publicado: (2013)

WHY STOP? A prospective observational vignette-based study to determine the cognitive-behavioural effects of rapid diagnostic PCR-based point-of-care test results on antibiotic cessation in ICU infections
por: Singh, Suveer, et al.
Publicado: (2023)

750 Effectiveness, Safety, and Impact on Healthcare Decongestion by a Busy Canadian Infusion Centre for Outpatient Parenteral Antimicrobial Therapy
por: Afra, Kevin, et al.
Publicado: (2014)

Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry
por: Martone, W J, et al.
Publicado: (2008)

Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis
por: Duncan, Christopher J. A., et al.
Publicado: (2013)

Comparing Injecting Drug Users with Others Receiving Outpatient Parenteral Antibiotic Therapy
por: Dobson, Pauline M, et al.
Publicado: (2017)

Twice daily cefazolin is effective for treatment of serious methicillin-sensitive Staphylococcus aureus infection in an outpatient parenteral antimicrobial therapy program
por: Birrell, Michael T., et al.
Publicado: (2019)

Is once enough? Understanding the preferences of COPD and asthma patients for once- versus twice-daily treatment
por: Horne, Rob
Publicado: (2013)

Prognostic Modeling of COVID-19 Using Artificial Intelligence in the United Kingdom: Model Development and Validation
por: Abdulaal, Ahmed, et al.
Publicado: (2020)

Once-daily treatment of ADHD with guanfacine: patient implications
por: Strange, Brandon C
Publicado: (2008)

The use of once-daily dosing of gentamicin in obstetrics and gynecology.
por: Wiesenfeld, H C, et al.
Publicado: (1998)

Once-daily transdermal rivastigmine in the treatment of Alzheimer’s disease
por: Wentrup, Andreas, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2gcei66dajq1kcebnlnpkna5mq